Hydration  ||| S:0 E:10 ||| NNP
and  ||| S:10 E:14 ||| CC
electrolyte  ||| S:14 E:26 ||| JJ
balance  ||| S:26 E:34 ||| NN
in  ||| S:34 E:37 ||| IN
horses  ||| S:37 E:44 ||| NNS
during  ||| S:44 E:51 ||| IN
an  ||| S:51 E:54 ||| DT
endurance  ||| S:54 E:64 ||| JJ
season  ||| S:64 E:71 ||| NN
Limited  ||| S:71 E:79 ||| JJ
information  ||| S:79 E:91 ||| NN
exists  ||| S:91 E:98 ||| VBZ
about  ||| S:98 E:104 ||| IN
the  ||| S:104 E:108 ||| DT
physiological  ||| S:108 E:122 ||| JJ
training-induced  ||| S:122 E:139 ||| JJ
changes  ||| S:139 E:147 ||| NNS
in  ||| S:147 E:150 ||| IN
electrolyte  ||| S:150 E:162 ||| JJ
balance  ||| S:162 E:170 ||| NN
of  ||| S:170 E:173 ||| IN
horses  ||| S:173 E:180 ||| NNS
competing  ||| S:180 E:190 ||| VBG
in  ||| S:190 E:193 ||| IN
long  ||| S:193 E:198 ||| JJ
distance  ||| S:198 E:207 ||| NN
endurance  ||| S:207 E:217 ||| NN
races ||| S:217 E:222 ||| NNS
.  ||| S:222 E:224 ||| .
To  ||| S:224 E:227 ||| TO
determine  ||| S:227 E:237 ||| VB
the  ||| S:237 E:241 ||| DT
effects  ||| S:241 E:249 ||| NNS
of  ||| S:249 E:252 ||| IN
endurance  ||| S:252 E:262 ||| JJ
training  ||| S:262 E:271 ||| NN
and  ||| S:271 E:275 ||| CC
racing  ||| S:275 E:282 ||| VBG
on  ||| S:282 E:285 ||| IN
hydration  ||| S:285 E:295 ||| NN
and  ||| S:295 E:299 ||| CC
electrolyte  ||| S:299 E:311 ||| JJ
balance  ||| S:311 E:319 ||| NN
in  ||| S:319 E:322 ||| IN
horses ||| S:322 E:328 ||| NNS
.  ||| S:328 E:330 ||| .
Blood  ||| S:330 E:336 ||| NN
and  ||| S:336 E:340 ||| CC
urine  ||| S:340 E:346 ||| NN
were  ||| S:346 E:351 ||| VBD
sampled  ||| S:351 E:359 ||| VBN
at  ||| S:359 E:362 ||| IN
rest  ||| S:362 E:367 ||| NN
in  ||| S:367 E:370 ||| IN
8  ||| S:370 E:372 ||| CD
endurance  ||| S:372 E:382 ||| CD
horses  ||| S:382 E:389 ||| NNS
before  ||| S:389 E:396 ||| IN
training  ||| S:396 E:405 ||| NN
and  ||| S:405 E:409 ||| CC
after  ||| S:409 E:415 ||| IN
two  ||| S:415 E:419 ||| CD
11  ||| S:419 E:422 ||| CD
week  ||| S:422 E:427 ||| NN
training  ||| S:427 E:436 ||| NN
periods  ||| S:436 E:444 ||| NNS
( ||| S:444 E:445 ||| -LRB-
T1  ||| S:445 E:448 ||| NNP
and  ||| S:448 E:452 ||| CC
T2 ||| S:452 E:454 ||| CD
) ||| S:454 E:455 ||| -RRB-
.  ||| S:455 E:457 ||| .
Each  ||| S:457 E:462 ||| DT
training  ||| S:462 E:471 ||| NN
was  ||| S:471 E:475 ||| VBD
followed  ||| S:475 E:484 ||| VBN
by  ||| S:484 E:487 ||| IN
a  ||| S:487 E:489 ||| DT
120  ||| S:489 E:493 ||| CD
km  ||| S:493 E:496 ||| CD
endurance  ||| S:496 E:506 ||| JJ
ride  ||| S:506 E:511 ||| NN
and  ||| S:511 E:515 ||| CC
horses  ||| S:515 E:522 ||| NNS
were  ||| S:522 E:527 ||| VBD
sampled  ||| S:527 E:535 ||| VBN
before ||| S:535 E:541 ||| RB
,  ||| S:541 E:543 ||| ,
during  ||| S:543 E:550 ||| IN
and  ||| S:550 E:554 ||| CC
2  ||| S:554 E:556 ||| CD
h  ||| S:556 E:558 ||| NN
after  ||| S:558 E:564 ||| IN
the  ||| S:564 E:568 ||| DT
rides ||| S:568 E:573 ||| NNS
.  ||| S:573 E:575 ||| .
Blood  ||| S:575 E:581 ||| NN
was  ||| S:581 E:585 ||| VBD
analysed  ||| S:585 E:594 ||| VBN
for  ||| S:594 E:598 ||| IN
packed  ||| S:598 E:605 ||| JJ
cell  ||| S:605 E:610 ||| NN
volume  ||| S:610 E:617 ||| NN
( ||| S:617 E:618 ||| -LRB-
PCV ||| S:618 E:621 ||| NNP
) ||| S:621 E:622 ||| -RRB-
,  ||| S:622 E:624 ||| ,
total  ||| S:624 E:630 ||| JJ
protein  ||| S:630 E:638 ||| NN
( ||| S:638 E:639 ||| -LRB-
TP ||| S:639 E:641 ||| NNP
) ||| S:641 E:642 ||| -RRB-
,  ||| S:642 E:644 ||| ,
urea ||| S:644 E:648 ||| NN
,  ||| S:648 E:650 ||| ,
creatinine  ||| S:650 E:661 ||| NN
and  ||| S:661 E:665 ||| CC
electrolyte  ||| S:665 E:677 ||| JJ
concentrations ||| S:677 E:691 ||| NNS
.  ||| S:691 E:693 ||| .
Urine  ||| S:693 E:699 ||| NNP
was  ||| S:699 E:703 ||| VBD
analysed  ||| S:703 E:712 ||| VBN
for  ||| S:712 E:716 ||| IN
pH ||| S:716 E:718 ||| NNP
,  ||| S:718 E:720 ||| ,
specific  ||| S:720 E:729 ||| JJ
gravity ||| S:729 E:736 ||| NN
,  ||| S:736 E:738 ||| ,
creatinine  ||| S:738 E:749 ||| NN
and  ||| S:749 E:753 ||| CC
electrolyte  ||| S:753 E:765 ||| JJ
concentrations ||| S:765 E:779 ||| NNS
,  ||| S:779 E:781 ||| ,
which  ||| S:781 E:787 ||| WDT
allowed  ||| S:787 E:795 ||| VBD
calculation  ||| S:795 E:807 ||| VBN
of  ||| S:807 E:810 ||| IN
fractional  ||| S:810 E:821 ||| JJ
excretion  ||| S:821 E:831 ||| NN
of  ||| S:831 E:834 ||| IN
electrolytes  ||| S:834 E:847 ||| NNS
( ||| S:847 E:848 ||| -LRB-
FE ||| S:848 E:850 ||| NNP
) ||| S:850 E:851 ||| -RRB-
.  ||| S:851 E:853 ||| .
Changes  ||| S:853 E:861 ||| NNS
associated  ||| S:861 E:872 ||| VBN
with  ||| S:872 E:877 ||| IN
training  ||| S:877 E:886 ||| NN
and  ||| S:886 E:890 ||| CC
with  ||| S:890 E:895 ||| IN
the  ||| S:895 E:899 ||| DT
rides  ||| S:899 E:905 ||| NNS
were  ||| S:905 E:910 ||| VBD
assessed  ||| S:910 E:919 ||| VBN
using  ||| S:919 E:925 ||| VBG
a  ||| S:925 E:927 ||| DT
Student  ||| S:927 E:935 ||| NN
paired  ||| S:935 E:942 ||| VBN
t  ||| S:942 E:944 ||| JJ
test  ||| S:944 E:949 ||| NN
( ||| S:949 E:950 ||| -LRB-
P  ||| S:950 E:952 ||| NNP
â‰¤  ||| S:952 E:954 ||| CD
0.05 ||| S:954 E:958 ||| CD
) ||| S:958 E:959 ||| -RRB-
.  ||| S:959 E:961 ||| .
Plasma  ||| S:961 E:968 ||| NNP
TP ||| S:968 E:970 ||| NNP
,  ||| S:970 E:972 ||| ,
urea ||| S:972 E:976 ||| NN
,  ||| S:976 E:978 ||| ,
creatinine  ||| S:978 E:989 ||| NN
and  ||| S:989 E:993 ||| CC
sodium  ||| S:993 E:1000 ||| JJ
concentrations  ||| S:1000 E:1015 ||| NNS
increased  ||| S:1015 E:1025 ||| VBN
during  ||| S:1025 E:1032 ||| IN
T1  ||| S:1032 E:1035 ||| NNP
and  ||| S:1035 E:1039 ||| CC
PCV  ||| S:1039 E:1043 ||| NNP
decreased  ||| S:1043 E:1053 ||| VBD
significantly  ||| S:1053 E:1067 ||| RB
during  ||| S:1067 E:1074 ||| IN
T2 ||| S:1074 E:1076 ||| CD
.  ||| S:1076 E:1078 ||| .
FE ||| S:1078 E:1080 ||| NNP
( ||| S:1080 E:1081 ||| -LRB-
Cl ||| S:1081 E:1083 ||| NNP
)  ||| S:1083 E:1085 ||| -RRB-
increased  ||| S:1085 E:1095 ||| VBD
during  ||| S:1095 E:1102 ||| IN
T1  ||| S:1102 E:1105 ||| NNP
then  ||| S:1105 E:1110 ||| RB
decreased ||| S:1110 E:1119 ||| VBN
.  ||| S:1119 E:1121 ||| .
FE ||| S:1121 E:1123 ||| NNP
( ||| S:1123 E:1124 ||| -LRB-
K ||| S:1124 E:1125 ||| NNP
)  ||| S:1125 E:1127 ||| -RRB-
increased  ||| S:1127 E:1137 ||| VBD
significantly  ||| S:1137 E:1151 ||| RB
during  ||| S:1151 E:1158 ||| IN
both  ||| S:1158 E:1163 ||| DT
training  ||| S:1163 E:1172 ||| NN
periods ||| S:1172 E:1179 ||| NNS
.  ||| S:1179 E:1181 ||| .
Other  ||| S:1181 E:1187 ||| JJ
blood  ||| S:1187 E:1193 ||| NN
and  ||| S:1193 E:1197 ||| CC
urine  ||| S:1197 E:1203 ||| JJ
parameters  ||| S:1203 E:1214 ||| NNS
did  ||| S:1214 E:1218 ||| VBD
not  ||| S:1218 E:1222 ||| RB
show  ||| S:1222 E:1227 ||| VB
remarkable  ||| S:1227 E:1238 ||| JJ
changes  ||| S:1238 E:1246 ||| NNS
with  ||| S:1246 E:1251 ||| IN
training ||| S:1251 E:1259 ||| NN
.  ||| S:1259 E:1261 ||| .
PCV ||| S:1261 E:1264 ||| NNP
,  ||| S:1264 E:1266 ||| ,
plasma  ||| S:1266 E:1273 ||| VBG
TP ||| S:1273 E:1275 ||| NNP
,  ||| S:1275 E:1277 ||| ,
urea ||| S:1277 E:1281 ||| NN
,  ||| S:1281 E:1283 ||| ,
creatinine  ||| S:1283 E:1294 ||| NN
and  ||| S:1294 E:1298 ||| CC
total  ||| S:1298 E:1304 ||| NN
Ca  ||| S:1304 E:1307 ||| MD
concentrations  ||| S:1307 E:1322 ||| VB
increased  ||| S:1322 E:1332 ||| VBN
and  ||| S:1332 E:1336 ||| CC
plasma  ||| S:1336 E:1343 ||| JJ
Na ||| S:1343 E:1345 ||| NNP
( ||| S:1345 E:1346 ||| -LRB-
+ ||| S:1346 E:1347 ||| NNP
)  ||| S:1347 E:1349 ||| -RRB-
and  ||| S:1349 E:1353 ||| CC
Cl ||| S:1353 E:1355 ||| NNP
( ||| S:1355 E:1356 ||| -LRB-
- ||| S:1356 E:1357 ||| NNP
)  ||| S:1357 E:1359 ||| -RRB-
concentrations  ||| S:1359 E:1374 ||| NNS
decreased  ||| S:1374 E:1384 ||| VBD
during  ||| S:1384 E:1391 ||| IN
both  ||| S:1391 E:1396 ||| DT
rides ||| S:1396 E:1401 ||| NNS
.  ||| S:1401 E:1403 ||| .
Urine  ||| S:1403 E:1409 ||| JJ
concentrations  ||| S:1409 E:1424 ||| NNS
of  ||| S:1424 E:1427 ||| IN
Na ||| S:1427 E:1429 ||| NNP
( ||| S:1429 E:1430 ||| -LRB-
+ ||| S:1430 E:1431 ||| NNP
) ||| S:1431 E:1432 ||| -RRB-
,  ||| S:1432 E:1434 ||| ,
K ||| S:1434 E:1435 ||| NNP
( ||| S:1435 E:1436 ||| -LRB-
+ ||| S:1436 E:1437 ||| NNP
)  ||| S:1437 E:1439 ||| -RRB-
and  ||| S:1439 E:1443 ||| CC
Cl ||| S:1443 E:1445 ||| NNP
( ||| S:1445 E:1446 ||| -LRB-
- ||| S:1446 E:1447 ||| NNP
) ||| S:1447 E:1448 ||| -RRB-
,  ||| S:1448 E:1450 ||| ,
FE ||| S:1450 E:1452 ||| NNP
( ||| S:1452 E:1453 ||| -LRB-
Na ||| S:1453 E:1455 ||| NNP
)  ||| S:1455 E:1457 ||| -RRB-
and  ||| S:1457 E:1461 ||| CC
FE ||| S:1461 E:1463 ||| NNP
( ||| S:1463 E:1464 ||| -LRB-
Cl ||| S:1464 E:1466 ||| NNP
)  ||| S:1466 E:1468 ||| -RRB-
decreased  ||| S:1468 E:1478 ||| VBD
during  ||| S:1478 E:1485 ||| IN
the  ||| S:1485 E:1489 ||| DT
rides  ||| S:1489 E:1495 ||| NNS
while  ||| S:1495 E:1501 ||| IN
urinary  ||| S:1501 E:1509 ||| JJ
creatinine  ||| S:1509 E:1520 ||| NN
increased ||| S:1520 E:1529 ||| VBD
.  ||| S:1529 E:1531 ||| .
FE ||| S:1531 E:1533 ||| NNP
( ||| S:1533 E:1534 ||| -LRB-
K ||| S:1534 E:1535 ||| NNP
)  ||| S:1535 E:1537 ||| -RRB-
increased  ||| S:1537 E:1547 ||| VBD
during  ||| S:1547 E:1554 ||| IN
the  ||| S:1554 E:1558 ||| DT
first  ||| S:1558 E:1564 ||| JJ
part  ||| S:1564 E:1569 ||| NN
of  ||| S:1569 E:1572 ||| IN
the  ||| S:1572 E:1576 ||| DT
rides  ||| S:1576 E:1582 ||| NNS
then  ||| S:1582 E:1587 ||| RB
decreased ||| S:1587 E:1596 ||| VBN
.  ||| S:1596 E:1598 ||| .
These  ||| S:1598 E:1604 ||| DT
data  ||| S:1604 E:1609 ||| NNS
contribute  ||| S:1609 E:1620 ||| VBP
to  ||| S:1620 E:1623 ||| TO
the  ||| S:1623 E:1627 ||| DT
understanding  ||| S:1627 E:1641 ||| NN
of  ||| S:1641 E:1644 ||| IN
changes  ||| S:1644 E:1652 ||| NNS
associated  ||| S:1652 E:1663 ||| VBN
with  ||| S:1663 E:1668 ||| IN
training  ||| S:1668 E:1677 ||| NN
and  ||| S:1677 E:1681 ||| CC
prolonged  ||| S:1681 E:1691 ||| JJ
endurance  ||| S:1691 E:1701 ||| JJ
exercise ||| S:1701 E:1709 ||| NN
.  ||| S:1709 E:1711 ||| .
